Mainstream

Mainstream

Impact of COVID-19 infection in chronic rheumatic diseases treated with immunosuppressive drugs

Structure

DURATION

6 MONTHS

BUDGET

€ 742.926,31

FUNDING

€ 401.402,67

Project mission

The project proposes the analysis of the adaptive immune response and the antibody response to SARS-CoV-2 in paucisymptomatic subjects with severe symptoms.
The strategy includes an analysis of the adaptive and antibody response, the profile of viral antigens in biological fluids and the development of an immuno-diagnostic assay.

Project Partners

-	Fondazione Istituto Nazionale di Genetica Molecolare – INGM
DIA.PRO Diagnostic Bioprobes Srl
Azienda Socio Sanitaria Territoriale (ASST) Centro Specialistico Ortopedico Traumatologico Gaetano Pini-CTO
Consorzio Italbiotec
Address

Legal and administrative residence
Via Gaudenzio Fantoli 16/15
20138 Milano